Rest-Of-The-Asia-Pacific Mice Model Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of The Asia Pacific Mice Model Market analysis

Part of: Mice Model Market (Global)

The Rest Of The Asia Pacific Mice Model Market was valued at $0.17 Million in 2025 and projected to reach to $0.24 Million by 2030, representing a compound annual growth rate of 6.5%. Rest Of The Asia Pacific's mice model market is positioned for moderate but consistent growth as regional economies invest in life sciences infrastructure and pharmaceutical R&D capabilities.

Rest Of The Asia Pacific Mice Model Market Trends and Insights

GCC Countries' mice model market is expanding at a compound annual growth rate (CAGR) of 6.5%, driven by increasing investment in biomedical research and pharmaceutical development across the region.
The growth trajectory in GCC Countries reflects rising demand for preclinical testing models and enhanced regulatory frameworks supporting life sciences research. GCC Countries' mice model market benefits from growing healthcare infrastructure and government initiatives to establish research hubs.
Between 2025 and 2030, GCC Countries is expected to see accelerated adoption of genetically modified and specialized mouse models for disease research.
The market in GCC Countries is characterized by partnerships between regional institutions and international research organizations, facilitating technology transfer and market expansion..

Key Market Statistics

CAGR (2025-2030) 6.5% CAGR
Market Size, 2025 ~USD 0.17 Million
Forecast, 2030 ~USD 0.24 Million
Country Rest Of The Asia Pacific

Rest Of The Asia Pacific Mice Model Market Overview

Market Size & Growth :

Rest Of The Asia Pacific mice model market is valued at $0.17 million in 2025, projected to reach $0.24 million by 2030, representing a steady CAGR of 6.5% over the forecast period.

Regional Research Investment :

Increasing biomedical research funding and pharmaceutical development initiatives across emerging Asia Pacific economies are driving demand for advanced mice models in preclinical testing.

Below Global Growth Rate :

While Rest Of The Asia Pacific grows at 6.5% CAGR, the global mice model market expands at 10% CAGR, indicating untapped growth potential in this region as research infrastructure develops.

Emerging Market Opportunity :

Developing nations in Asia Pacific are establishing new research institutions and CROs, creating expanding opportunities for mice model suppliers and contract research organizations.

Rest Of The Asia Pacific Mice Model Market Dynamics

The region's lower market penetration compared to developed markets presents significant expansion opportunities as research institutions modernize and increase preclinical testing activities.
Government initiatives supporting biomedical innovation and rising collaborations with global pharmaceutical companies are expected to accelerate market development through 2030. The 6.5% CAGR reflects the region's gradual transition toward advanced research methodologies and increased adoption of mice models in drug discovery and development.
Emerging markets within Asia Pacific are establishing specialized breeding facilities and research centers, reducing dependency on imported models.
Strategic partnerships between regional research organizations and international biotech firms will likely enhance market accessibility and drive sustained growth in this developing segment..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

GCC Countries' mice model market is valued at $0.17 million in 2025 and expected to grow to $0.24 million by 2030.
GCC Countries demonstrates a 6.5% CAGR, reflecting moderate but consistent market expansion in preclinical research.
Government-backed research initiatives and healthcare investments are primary growth catalysts in GCC Countries.
GCC Countries' market is increasingly characterized by international collaborations and adoption of advanced mouse model technologies.

Mice Model Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	SERVICES (Model Type & Service)
Forecast Period	2025�2030
Growth Rate	CAGR of 10% from 2025 to 2030
Largest Segment	MODEL TYPE (Model Type & Service)
Market Size Base Year (Billions)	~USD 1.7 (2025)
Revenue Forecast (Billions)	~USD 2.74 (2030)
Segments Covered	Model Type & Service, Type, Technology, Application, Therapeutic Area

Rest Of The Asia Pacific Mice Model Market Report Segmentation

5 segment dimensions are covered across the global market.

By Model Type & Service

Model Type
Services

By Type

Breeding Services
Cryopreservation Services
Genetically Engineered Mice
Hybrid/Congenic Mice
Inbred Mice
Other Services
Outbred Mice
Quarantine Services
Rederivation Services

By Technology

Crispr/Cas9
Embryonic Stem Cell Injections
Microinjections
Nuclear Transfer Technique
Other Technologies

By Application

Drug Discovery & Development
Personalized Medicine
Research Applications

By Therapeutic Area

Cardiovascular Diseases
Immunology
Metabolic Diseases
Neurology
Oncology
Other Therapeutic Areas

Target Audience

Pharmaceutical Companies : Need regional market data to plan preclinical research operations, establish breeding partnerships, and allocate R&D budgets across Rest Of The Asia Pacific markets.
Contract Research Organizations : Require market insights to identify expansion opportunities, assess demand for mice model services, and develop regional service offerings in Asia Pacific.
Laboratory Animal Suppliers : Seek market intelligence to understand regional demand patterns, competitive positioning, and growth opportunities for mice breeding and distribution in Asia Pacific.
Research Institutions : Need market data to benchmark regional research capabilities, identify funding trends, and plan facility investments aligned with market growth in Rest Of The Asia Pacific.
Investment & Venture Capital Firms : Require detailed market analysis to evaluate investment opportunities in biotech, CROs, and research infrastructure companies operating in Rest Of The Asia Pacific region.

Key Companies in the Rest Of The Asia Pacific Mice Model Market

Company	HQ	Ownership	Strongest segments
HORIZON DISCOVERY GROUP PLC	United Kingdom	Private Company	Screening,Research Reagents,Diagnostics,
LABORATORY CORPORATION OF AMERICA HOLDINGS	United States	Public Company	Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women�s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D),
CHARLES RIVER LABORATORIES	United States	Public Company	Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions,
THE JACKSON LABORATORY	United States	Foundation/Charitable Institution	Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models,
INOTIV	United States	Public Company	Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
JSR CORPORATION	Japan	Private Company	Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support),
BIOCYTOGEN	China	Public Company	Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales),
SHANGHAI MODEL ORGANISMS CENTER, INC.	China	Public Company	Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis),
TRANS GENIC INC.	Japan	Public Company	Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis,
HARBOUR BIOMED	China	Public Company	Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio),
GENOWAY	France	Public Company	Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom),
GEMPHARMATECH	China	Public Company	Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services,
VIVO BIO TECH LTD.	India	Public Company	In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services,

HORIZON DISCOVERY GROUP PLC

Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.

LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.

THE JACKSON LABORATORY

The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.

INOTIV

Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.

JSR CORPORATION

JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.

BIOCYTOGEN

Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.

SHANGHAI MODEL ORGANISMS CENTER, INC.

Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.

TRANS GENIC INC.

Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.

HARBOUR BIOMED

Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.

GENOWAY

Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.

GEMPHARMATECH

GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.

VIVO BIO TECH LTD.

Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.

Reasons to Buy this Report

Regional Market Sizing : Obtain precise market valuation and growth projections specific to Rest Of The Asia Pacific, enabling accurate budget allocation and investment decisions in this emerging region.
Competitive Landscape Intelligence : Understand regional market dynamics, key players, and competitive positioning within Rest Of The Asia Pacific to identify partnership and expansion opportunities.
Growth Driver Analysis : Identify specific factors driving 6.5% CAGR growth in Rest Of The Asia Pacific, including research funding trends, regulatory changes, and institutional development patterns.
Strategic Market Entry : Develop informed market entry strategies for Rest Of The Asia Pacific with detailed insights on market maturity, infrastructure gaps, and emerging demand centers.
Forecast-Based Planning : Leverage 2030 market projections for Rest Of The Asia Pacific to plan long-term capacity, supply chain, and resource allocation strategies with confidence.

Frequently asked questions

What is the current market size of mice models in GCC Countries?

The mice model market in GCC Countries was valued at $0.17 million in 2025 and is projected to reach $0.24 million by 2030.

What is the growth rate of the mice model market in GCC Countries?

GCC Countries' mice model market is growing at a CAGR of 6.5% from 2025 to 2030.

What factors are driving growth in GCC Countries' mice model market?

Growth in GCC Countries is driven by increased biomedical research investment, government healthcare initiatives, regulatory framework improvements, and international research partnerships.

Which mouse model types are most in demand in GCC Countries?

GCC Countries shows rising demand for genetically modified mice, disease-specific models, and specialized research strains used in pharmaceutical and academic research.

How does GCC Countries' market compare to global trends?

While the global mice model market grows at 10% CAGR, GCC Countries expands at 6.5% CAGR, reflecting a developing but emerging regional research ecosystem.

RESEARCH METHODOLOGY

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.

Stakeholders

Manufacturers & Distributors of Mice Models
CROs & CDMOs
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Market Research & Consulting Firms
Researchers & Scientists
Regulatory Authorities & Institutes

Report Objectives

To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.

Get the Full Mice Model Market Report

Full forecast, segment splits, and company analysis for all Mice Model Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies